Who owns BRIACELL THERAPEUTICS CORP?
- Ticker: BCTXL
- CUSIP Number: 107930125
Tip: Access positions for across all investors
Analyze quarterly positions in Briacell Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Briacell Therapeutics Corp stock
Who bought or sold BRIACELL THERAPEUTICS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 1.0M | $1.0M | 100% | Mar 2026 |
|
| Armistice Capital | 537k | $553k | 100% | Mar 2026 |
|
| Sabby Management | 381k | $392k | 100% | Mar 2026 |
|
| Cable Car Capital | 322k | $332k | 100% | Mar 2026 |
|
| Empery Asset Management | 300k | $309k | 100% | Mar 2026 |
|
| Heights Capital Management | 300k | $300k | 100% | Mar 2026 |
|
| MYDA Advisors | 200k | $206k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 125k | $125k | 100% | Mar 2026 |
|
| Warberg Asset Management | 115k | $119k | 100% | Mar 2026 |
|
| Clear Street Group | 104k | $107k | 100% | Mar 2026 |
|
| Iridian Asset Management | 65k | $67k | 100% | Mar 2026 |
|
| Susquehanna International | 24k | $24k | 100% | Mar 2026 |
|
| Boothbay Fund Management | 20k | $84k | 100% | Mar 2026 |
|